Please login to the form below

Not currently logged in

Sanofi takes anti-counterfeiting message to the skies

Hopes to reach four million passengers with Air France film

Sanofi has launched a campaign warning people of the risks involved with buying and using counterfeit medicines.

An educational film created by the Paris-based pharma company will be shown on board long-haul Air France flights during December this year, with the hope of reaching four million passengers.

In addition to the film, the campaign's counterfeit medicine awareness messages will also appear in Air France Magazine and inside the airline's airport lounges.

"Sanofi is mobilised to fight against counterfeit medicines, which represent a threat for public health, through active cooperation with governments and international organisations and contribution to various information and prevention programmes,” said Philippe Peyre, senior vice president general secretary, Sanofi.

The company's new campaign warns that counterfeit drugs may contain inactive ingredients, be ineffective at treating disease and may even contain harmful toxic substances.

Citing World Health Organization (WHO) data, the company says that over 50 per cent of drugs sold on the internet are counterfeit.

The Air France campaign is the latest in a series of initiatives that Sanofi has been involved with since opening an 'anti counterfeiting laboratory' in 2008.

Based in the central French city of Tours, the facility devises solutions for the protection and traceability of the company's products, while also monitoring and collecting information on counterfeits.

30th November 2012

From: Marketing, Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...